Mohammed Y Almaghrabi is a currently working as a Head of Radiation Oncology at Prince Faisal Cancer Centre, Saudi Arabia. He holds his Research experience from University of Ottawa Canada. He has been a recipient of many award and grants. His research experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests as a reflects in his wide range of publications in various national and international journals. His research interest includes Oncology, Radialogy, Hepatology, and Clinical Oncology etc.

His research interest includes Oncology, Radialogy, Hepatology, and Clinical Oncology etc.

Professor Anderson holds the Established Chair in Biomedical Sciences at the University of Bradford. She obtained her first degree in the University of Wales and second degrees in the Faculty of Medicine, University of Manchester. She has an H index of 57, 450+ peer-reviewed papers, 8 books, has successfully supervised 26 PhDs, and been a member of editorial boards of 10 international journals. She has been or is Editor in Chief of a book Series on toxicology for J.Wiley and sons and the Royal Society of Chemistry respectively. She gives key note addresses at various international meetings. She is a consultant for many international organisations, such as the WHO, NATO, TWAS, UNIDO and the OECD

Cancer, oxygen radicals, human biomonitoring, unbalanced precursor pools, dietary imbalance, male-mediated developmental defects, nanotoxicology, general toxicology

Dr. Alvaro Macieira-Coelho is a Research Director at the French National Institute of Health. He received an MD from the University of Lisbon, Portugal, and a PhD from the University of Uppsala Sweden. He made an internship at the University Hospital in Lisbon and was a research associate at the Wistar Institute in Philadelphia (USA) and at the Department of Cell Biology of the University of Uppsala (Sweden). He became Head of the Department of Cell Pathology at the Cancer Institute in Villejuif (France) and was a visiting Professor at the University of Linkoping (Sweden). He published 150 papers in professional Journals and 9 books on cancer and aging. He received the following awards: Fritz Verzar Prize (University of Vienna, Austria), “Seeds of Science”, Career Prize (Lisbon, Portugal), Dr. Honoris Causa (University of Linkoping, Sweden), Johananof International Visiting Professor (Institute Mario Negri, Milano, Italy).

Cancer and Aging, Biology of Normal Proliferating Cells in Vitro, Cell immortalization, Biology of Aging, Molecular Biology.

Alok De has received his PhD from University of Calcutta. He is a Research Biologist at Kansas City VA Medical Center. His research focuses on to use the extract of Emblica officinalis as an alternative or adjunct therapeutic agent in helping to fight ovarian cancer . He has published more than 45 papers in reputed journals. He has been serving as reviewers of many journals and as an Editorial Board Member of Cancer Cell and Microenvironment

His basic research interest is in the filed of Oncology, Gynecologic cancer, Tumor biology,Cancer Cell sciences etc.

Sadir Al Rawi currently is the Director of Surgical Oncology Services of Alzahra Cancer Center, Dubai and is the interim Chair of Department of surgery since October 2013. Prior to that,Alrawi was an assistant professor in the Department of Surgery/Division of Surgical Oncology at University of Florida, Jacksonville. He trained in various academic institutes in Surgical Oncology all over including Roswell Park, Cancer institute, Buffalo, Royal Free Hospital, UC of London and Ninewells Hospital, Dundee, United Kingdom. Sadir Al Rawi is American board certified, completed his Head & Neck fellowship and Surgical Oncology fellowship at Roswell Park Cancer institute (NCI) designated in 2006.Dr Alrawi did advanced Laparoscpic oncology training with Professor Alfred Cuschieri in Dundee 1992-1993, advanced colorectal oncology training with E Lloyd Davis in Cornwall, England 1993-1995 and advanced surgical oncology with Professor Marc Winslett, London 1995-1996.

Dr Alrawi major interest is Gastrointestinal Oncology, including Esophageal, Gastric, Pancreas, Liver and colonic surgery with special interest in endocrine surgery including thyroid , parathyroid and adrenal surgery.

Mohammed Y Almaghrabi is a currently working as a Head of Radiation Oncology at Prince Faisal Cancer Centre, Saudi Arabia. He holds his Research experience from University of Ottawa Canada. He has been a recipient of many award and grants. His research experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests as a reflects in his wide range of publications in various national and international journals. His research interest includes Oncology, Radialogy, Hepatology, and Clinical Oncology etc.

His research interest includes Oncology, Radialogy, Hepatology, and Clinical Oncology etc.

Abdolrahman Shams Nateri Completed his doctrate degree on the genetic engineering of Picornavirus, human Parechovirus 1,at the Essex Univ. later on in the year 2001, he joined as a member of Cancer Research UK (CR-UK) London Research Institute (previously known as ICRF), where he carried out his fundamental basic-research into the links between transcription, MAPKs signaling & diseases, including the cellular/molecular biology of cancer and also rewarded with publications with top journals.In 2007, he joined as a faculty of the UoN, where he intially started as a lecturer, and was promoted as an Associate Professor,his endless passion in cancer-biology and excellent achievements boasted publications in Nature, Science, etc and more recently J Exp Med & Stem Cells.

Gastrointestinal (GI) disorders (both neoplastic & non-neoplastic),Cancer Genetics, Transgenic Murine Technology, Stem Cells, Reprogramming of Cancer Cells and Links between Signalling, Transcription and Diseases,cellular basis of IES cell self-renewal, the interaction of stem cells with their specialized microenvironment (stem cell niche) and the relationship between stem cells and tumorigenesis.

Czerw Aleksandra, PhD, Expert in the field of health economics, organisation and management in the protection of health, medical services marketing. Assistant Professor at the Public Health Faculty of the Medical University of Warsaw. Author of numerous developments in the field of the strategic management including strategic analysis in the health protection sector. Member of the Regional and Local Analyses Centre. Co-operates with the pharmaceutical sector. Medicinal products marketing strategies consultant. Author of more than 100 national and international publications. Active member of numerous associations including: Polish Public Health Society, Polish Health Science Society, Polish Pharmaceutical Society, Polish Pharmacoecomic Society, Polish Economic Society.

Implementing market mechanisms in healthcare Organisation and management in the protection of health Medicinal product and health services’ marketing Health economics

José J. Jiménez-Moleón, Associate Professor of Preventive Medicine and Public Health at the University of Granada. His research subjects deal with the application of epidemiological method to the study of non-communicable diseases, including the etiology of cancer. The scientific production of his research activity stems from 12 competitive research projects (four as principal researcher) and 3 research contracts. This has resulted in 97 full-text scientific articles.

Public Health,Epidemiology, Medical & Health Profession Education,Epidemiology and Public Health,Statistical Analysis,Community Health,Obesity Epidemic, Research Methods.

Sadir Al Rawi currently is the Director of Surgical Oncology Services of Alzahra Cancer Center, Dubai and is the interim Chair of Department of surgery since October 2013. Prior to that,Alrawi was an assistant professor in the Department of Surgery/Division of Surgical Oncology at University of Florida, Jacksonville. He trained in various academic institutes in Surgical Oncology all over including Roswell Park, Cancer institute, Buffalo, Royal Free Hospital, UC of London and Ninewells Hospital, Dundee, United Kingdom. Sadir Al Rawi is American board certified, completed his Head & Neck fellowship and Surgical Oncology fellowship at Roswell Park Cancer institute (NCI) designated in 2006.Dr Alrawi did advanced Laparoscpic oncology training with Professor Alfred Cuschieri in Dundee 1992-1993, advanced colorectal oncology training with E Lloyd Davis in Cornwall, England 1993-1995 and advanced surgical oncology with Professor Marc Winslett, London 1995-1996.

Dr Alrawi major interest is Gastrointestinal Oncology, including Esophageal, Gastric, Pancreas, Liver and colonic surgery with special interest in endocrine surgery including thyroid , parathyroid and adrenal surgery,

Jiri Vachtenheim received his MD from the Charles University in Prague in 1981 and PhD (1985) in the biochemistry of melanoma at the same University. His postdoctoral studies were partly performed as fellowships in Great Britain and Belgium. His long-standing interest is the biology of melanoma, focused on the role of MITF, a central melanoma transcription factor and melanoma oncogene. Further studies were performed on other tumors, especially lung cancer. He has extended the interest in cancer molecular biology and elucidates also some deregulated signaling pathways in tumors, especially the Hedgehog/GLI pathway which regulates the tumor stemness. He is a member of several American societies for cancer, biochemistry and molecular biology. He is now an Associate Professor and Head of the Department of transcription and cell signaling at the Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic.

Community Health,Obesity Epidemic, Research Methods,Public Health,Epidemiology, Medical & Health Profession Education,Epidemiology and Public Health,Statistical Analysis.

Dr. Wu graduated from Nanjing Normal University in 1981 (BS), and obtained his PhD degree from Columbia University, USA in 1988. He then continuously conducted his postdoctoral research at Harvard University during 1988-1991. Thereafter, he moved to Singapore as an Assistant Professor at School of Biological Sciences of National University of Singapore. Started from 2000, he worked as a full professor at University of Science and Technology of China in Hefei, Anhui. His research interests focus on molecular mechanisms for p53-regulated tumor development and regulation of non-coding RNA in tumor metabolism. He has published more than 60 research papers on international peer-reviewed journals with more than 2900 citations.

His research interests focus on molecular mechanisms for p53-regulated tumor development and regulation of non-coding RNA in tumor metabolism. He has published more than 60 research papers on international peer-reviewed journals with more than 2900 citations.

Dr. Wen graduated from XiamenUniversity in 1982 (BS) and obtained his PhD from University of California, Los Angeles, USA in 1988. He has over 30 years of experience in biomedical research at various academic institutions in the USA, Singapore and China. Since 2002, he has been working as a full professor at University of Science and Technology of China, with a research interest focusing on nanobiology and nanomedicine. He has published over 80 research papers on international peer-reviewed journals with more than 3000 citations and has an H-index of 37.

His research interests focus is basically in the field of nanobiology and nanomedicine. He has published over 80 research papers on international peer-reviewed journals with more than 3000 citations and has an H-index of 37.